• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

药品不良反应报告术语使用的基本要求（八）：肾脏和泌尿系统疾病

Basic requirements for the use of terms for reporting adverse drug reactions (VIII): renal and urinary system disorders.

出版信息

Pharmacoepidemiol Drug Saf. 1997 May;6(3):203-11. doi: 10.1002/(SICI)1099-1557(199705)6:3<203::AID-PDS265>3.0.CO;2-I.

DOI:10.1002/(SICI)1099-1557(199705)6:3<203::AID-PDS265>3.0.CO;2-I
PMID:15073789
Abstract

This paper is the report of a meeting held in Geneva under the auspices of the Council for International Organizations of Medical Sciences (CIOMS) on 4-5 June 1996. It contains definitions of terms used in reporting adverse drug reactions of the system/organ class renal and urinary system disorders and basic requirements for their use.

摘要

本文是1996年6月4日至5日在国际医学科学组织理事会（CIOMS）主持下于日内瓦召开的一次会议的报告。它包含了在报告肾脏和泌尿系统疾病这一系统/器官类别的药物不良反应时所用术语的定义及其使用的基本要求。

相似文献

1
Basic requirements for the use of terms for reporting adverse drug reactions (VIII): renal and urinary system disorders.药品不良反应报告术语使用的基本要求（八）：肾脏和泌尿系统疾病
Pharmacoepidemiol Drug Saf. 1997 May;6(3):203-11. doi: 10.1002/(SICI)1099-1557(199705)6:3<203::AID-PDS265>3.0.CO;2-I.
2
Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XI): cardiovascular system disorders.药品不良反应报告术语的定义及使用基本要求（十一）：心血管系统疾病
Pharmacoepidemiol Drug Saf. 1998 Sep;7(5):351-7. doi: 10.1002/(SICI)1099-1557(199809/10)7:5<351::AID-PDS368>3.0.CO;2-0.
3
Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XII): collagen disorders and musculo-skeletal disorders.药品不良反应报告术语的定义及使用基本要求（十二）：胶原病和肌肉骨骼疾病
Pharmacoepidemiol Drug Saf. 1999 Mar;8(2):141-5. doi: 10.1002/(SICI)1099-1557(199903/04)8:2<141::AID-PDS410>3.0.CO;2-X.
4
Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XIII): clinical pathology and general disorders.
Pharmacoepidemiol Drug Saf. 1999 May;8(3):217-24. doi: 10.1002/(SICI)1099-1557(199905/06)8:3<217::AID-PDS415>3.0.CO;2-Q.
5
Definitions and basic requirements for the use of terms for reporting adverse drug reactions (X): gastrointestinal system disorders.
Pharmacoepidemiol Drug Saf. 1998 Jul;7(4):281-7. doi: 10.1002/(SICI)1099-1557(199807/08)7:4<281::AID-PDS325>3.0.CO;2-W.
6
Definitions of terms for reporting adverse drug reactions (IX): nervous system and psychiatric disorders.药品不良反应报告术语的定义（IX）：神经系统和精神障碍
Pharmacoepidemiol Drug Saf. 1998 Jan;7(1):39-49. doi: 10.1002/(SICI)1099-1557(199801/02)7:1<39::AID-PDS316>3.0.CO;2-Z.
7
[International reporting of adverse drug reactions. Final report of CIOMS ADR Working Group].
Therapie. 1991 May-Jun;46(3):173-8.
8
Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced cytopenia.
Int J Clin Pharmacol Ther Toxicol. 1991 Feb;29(2):75-81.
9
Establishing requirements for the use of terms for reporting adverse drug reactions (ADR). Consultant, Council for International Organizations of Medical Sciences (CIOMS), World Health Organization.制定药品不良反应（ADR）报告术语的使用要求。医学科学国际组织理事会（CIOMS）顾问，世界卫生组织。
Mater Med Pol. 1993 Jan-Mar;25(1):45-6.
10
Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting.药物不良反应因果关系评估的定义和标准的标准化。药物性血细胞减少症：一次国际共识会议报告。
Nouv Rev Fr Hematol (1978). 1991;33(3):257-62.

引用本文的文献

1
Harmonising adverse drug reaction terminology: the role of the Council for International Organizations of Medical Sciences.统一药品不良反应术语：国际医学科学组织理事会的作用
Drug Saf. 1998 Sep;19(3):165-72. doi: 10.2165/00002018-199819030-00001.
2
Good practice in the postmarketing surveillance of medicines.
Pharm World Sci. 1997 Aug;19(4):186-90. doi: 10.1023/a:1008610722972.